Edap TMS SA FOCL

What this company does

EDAP TMS S.A. is a medical technology company focused on the development, manufacturing, marketing and sale of non-invasive therapeutic ultrasound and energy-based medical devices. The company was founded in 1979 as a societe anonyme organized under the laws of France, and it is headquartered in Vaulx-en-Velin, France, operating in the United States, Europe, Asia and the rest of the world. The company's technologies are primarily used in urology, with a current focus on the treatment of prostate cancer, driven commercially by its flagship product, Focal One Robotic HIFU. EDAP has realigned its business to focus exclusively on applications leveraging its proprietary High Intensity Focused Ultrasound technology, commercialized through its flagship product, Focal One Robotic HIFU. Its business model includes generating revenue from the sale of capital equipment as well as recurring revenue from consumables and maintenance services associated with its installed base. As of December 31, 2025, the company employed 289 employees worldwide, with approximately 24% based in the United States and the remainder located internationally. EDAP is listed on The Nasdaq Global Market under the symbol EDAP.

Written from the business description in EDAP TMS S.A.'s annual report to the U.S. Securities and Exchange Commission, filed 25 March 2026. Every sentence was checked against that document before publication.